EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes
about
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialHost kinin B1 receptor plays a protective role against melanoma progression.Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.ESR1:ESTG bind the EBAG9 5' regionEstrogen-responsive EBAG9 gene expression
P2860
EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@en
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@nl
type
label
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@en
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@nl
prefLabel
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@en
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@nl
P2093
P2860
P356
P1433
P1476
EBAG9 modulates host immune de ...... oxic activity of T lymphocytes
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2014.40
P577
2014-11-03T00:00:00Z
P5875
P6179
1029879582